Wealth Awesome
Pre-market
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Buy the stocks you believe in, for less

For a limited time, trade fractional shares commission-free.¹

  • ✓Own a piece of your favourite companies without buying an entire share
  • ✓Stocks and ETFs, from as little as $1
  • ✓In any account: TFSA, FHSA, RRSP and more

¹Online fractional trades in North American equities under one share, Sep 15, 2026 to Oct 31, 2027. One qualifying order per security, per side, per day. Conditions apply.

Stocks/TSX-V/MGRO

MustGrow Biologics Corp. (MGRO : TSX-V)

$0.41CAD+0.00 (%)Close of 2026-11-10

Common Stock

Follow MGRO

MGRO

MustGrow Biologics Corp.

Source:WealthAwesomeWealthAwesome
↑ $0.01 (1.28%)
30 day period
$0.36$0.40$0.44Sep 28Oct 20Nov 10

Performance

1 Day

+1.23%

1 Week

+2.50%

1 Month

-3.53%

YTD

-34.92%

The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.

Key Statistics

Market Cap

$28.86M

52W High

$0.94

52W Low

$0.29

P/E Ratio

-

50 Day MA

$0.41

200 Day MA

$0.49

Beta

0.39

Dividend Yield

-

Performance history

MGRO returns since 2023

MustGrow Biologics Corp. has traded since Nov 2023 in our data, with 0 up years out of 2 full calendar years. Its deepest fall was −86.8% (Oct 2024 to Jul 2026).

1 year / yr

−40.2%

3 years / yr

−30.6%

5 years / yr

—

10 years / yr

—

Calendar-year returns

  • 2023*+7.5%
  • 2024−10.9%
  • 2025−45.2%
  • 2026*−37.3%

* Partial year (first year of data, or year to date).

$10,000 invested in MGRO

  • 1 year ago$5,985
  • 2023 (start of our data)$3,292
Best year
2024: −10.9%
Worst year
2025: −45.2%
All-time high in our data
$2 on Oct 28, 2024 · now −82.9%

Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.

Awesome Portfolio™

Looking past MGRO? Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
11/10/2026$0.40$0.40$0.40$0.40$0.402,000
11/9/2026$0.41$0.43$0.38$0.41$0.4145,500
11/6/2026$0.40$0.41$0.38$0.41$0.4117,500
11/5/2026$0.41$0.41$0.39$0.39$0.3913,525
11/4/2026$0.40$0.40$0.36$0.39$0.3953,557
11/3/2026$0.40$0.42$0.37$0.41$0.4169,200
11/2/2026$0.38$0.42$0.36$0.40$0.4096,500
10/30/2026$0.37$0.38$0.36$0.36$0.3625,741
10/29/2026$0.41$0.41$0.38$0.38$0.388,685
10/28/2026$0.42$0.43$0.38$0.38$0.3829,035

Analyst Price Targets

Based on analyst covering MGRO · as of Sep 30, 2026

📈

Wall Street analysts forecast MGRO stock price to rise 512.2% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$2.51

+512.2% Upside

Previously C$2.70 on Sep 17, 2026

Current Price

C$0.41

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MGRO's historical volatility

HistoricalForecast68%95%
C$0.11C$0.31C$0.51C$0.71C$0.91C$1.11TodayJun 29Sep 2Nov 10Dec 23Feb 5Mar 20

30-Day Vol

92.8%

Annualized

90-Day Vol

88.8%

Annualized

Trend (90d)

-30.7%

Annualized drift

90d Mean

C$0.35

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.38C$0.28 – C$0.52
60 trading daysC$0.37C$0.23 – C$0.58
90 trading daysC$0.35C$0.20 – C$0.62

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About MustGrow Biologics Corp.

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. Additionally, the company offers biological and regenerative agriculture solutions to support sustainable farming. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

Financials

Revenue (TTM)
$9.51M
EBITDA
$-4.27M
Profit Margin
-58.53%
ROE (TTM)
-222.54%
EPS (Diluted)
-0.08
Book Value
0.07

Classification

Sector
Materials
Industry
Chemicals
Group
Materials

Free newsletter

The Saturday TSX Wrap

Saturday morning

The week on the TSX, in five minutes

  • The biggest gainers and losers, and why they moved
  • Sector and momentum moves at a glance
  • The Canadian market stories you missed

Free. One email a week. Unsubscribe any time.

Common Questions About MGRO

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
BLUBluEnergies Ltd.$3.75+87.50%
TTGTrident Gold Corp.$0.15+66.67%
ABAAbasca Resources Inc.$0.09+54.55%
AXEAcceleware Ltd$0.14+50.00%
PNTRPantera Silver Corp$0.42+50.00%
OZOutback Goldfields Corp$0.40+37.93%
CPICarlton Precious Inc.$0.10+35.71%
AMMAlmaden Minerals Ltd.$0.23+35.29%

Latest MGRO news

Wire stories from the last 10 days. Links open the original publisher.